GREAT POINT PARTNERS LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share (UNCY)

Filing Manager
GREAT POINT PARTNERS LLC
Reporting Manager
Great Point Partners, LLC
Security
Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
UNCY
Shares outstanding
114,846,507 shares
Disclosed Ownership
11,473,166 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:39:41 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"GREAT POINT PARTNERS LLC disclosed 10% ownership in Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share (UNCY) on 31 Dec 2024."

Quick Takeaways

  • GREAT POINT PARTNERS LLC filed SCHEDULE 13G/A for Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share (UNCY).
  • Disclosed ownership: 10%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 16:39.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Great Point Partners, LLC 10% 11,473,166 0 11,473,166 /s/ Dr. Jeffrey R. Jay, M.D Dr. Jeffrey R. Jay, M.D - Senior Managing Member
Dr. Jeffrey R. Jay, M.D. 10% 11,473,166 0 11,473,166 /s/ Dr. Jeffrey R. Jay, M.D Dr. Jeffrey R. Jay, M.D
Ms. Lillian Nordahl 10% 11,473,166 0 11,473,166 /s/ Ms. Lillian Nordahl Ms. Lillian Nordahl

Sponsored